Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Digi International
DGII
$2.63B
| $2.19M | ﹤0.01% |
59,937
-17,196
| -22% | -$591K |
|
2802
Regenxbio
RGNX
$620M
| $2.18M | ﹤0.01% |
225,940
-13,595
| -6% | -$120K |
|
2803
Ecovyst
ECVT
$1.32B
| $2.17M | ﹤0.01% |
248,233
+41,516
| +20% | +$366K |
|
2804
CALL
GitLab
GTLB
$5.83B
| $2.17M | ﹤0.01% |
48,200
-26,800
| -36% | -$1.23M |
|
2805
Phreesia
PHR
$663M
| $2.17M | ﹤0.01% |
92,336
-25,415
| -22% | -$691K |
|
2806
Sharplink Inc
SBET
$1.29B
| $2.16M | ﹤0.01% |
+127,211
| New | +$2.5M |
|
2807
Innovative Industrial Properties
IIPR
$1.71B
| $2.16M | ﹤0.01% |
40,357
-13,467
| -25% | -$732K |
|
2808
Tennant Co
TNC
$1.43B
| $2.16M | ﹤0.01% |
26,628
-8,688
| -25% | -$710K |
|
|
MRC
2809
DELISTED
MRC Global
MRC
| $2.16M | ﹤0.01% |
149,670
-42,327
| -22% | -$603K |
|
2810
CALL
Array Technologies
ARRY
$803M
| $2.15M | ﹤0.01% |
264,300
-298,200
| -53% | -$2.26M |
|
2811
UFP Technologies
UFPT
$1.97B
| $2.15M | ﹤0.01% |
10,778
-4,396
| -29% | -$967K |
|
2812
PROG Holdings
PRG
$1.75B
| $2.15M | ﹤0.01% |
66,405
-223,367
| -77% | -$7.33M |
|
2813
Coastal Financial
CCB
$626M
| $2.15M | ﹤0.01% |
19,861
-12,145
| -38% | -$1.29M |
|
2814
GSK
GSK
$104B
| $2.15M | ﹤0.01% |
49,756
+44,977
| +941% | +$1.76M |
|
2815
Ascendis Pharma A/S
ASND
$16B
| $2.14M | ﹤0.01% |
10,782
-1,147
| -10% | -$214K |
|
2816
Rogers Corp
ROG
$2.21B
| $2.13M | ﹤0.01% |
26,505
-9,938
| -27% | -$740K |
|
2817
Northrim BanCorp
NRIM
$590M
| $2.13M | ﹤0.01% |
98,414
-9,586
| -9% | -$217K |
|
2818
CVR Energy
CVI
$3.58B
| $2.13M | ﹤0.01% |
58,416
-4,402
| -7% | -$132K |
|
|
XHR
2819
Xenia Hotels & Resorts
XHR
$1.9B
| $2.13M | ﹤0.01% |
155,214
-43,262
| -22% | -$588K |
|
2820
Janus International
JBI
$700M
| $2.13M | ﹤0.01% |
215,588
-57,192
| -21% | -$552K |
|
2821
SiteOne Landscape Supply
SITE
$4.12B
| $2.12M | ﹤0.01% |
16,491
-60,710
| -79% | -$8.24M |
|
|
LADR
2822
Ladder Capital
LADR
$1.21B
| $2.12M | ﹤0.01% |
194,602
-172,894
| -47% | -$1.95M |
|
2823
TotalEnergies
TTE
$195B
| $2.11M | ﹤0.01% |
35,408
-669,271
| -95% | -$41.3M |
|
|
PGRE
2824
DELISTED
Paramount Group
PGRE
| $2.11M | ﹤0.01% |
323,151
-33,435
| -9% | -$222K |
|
2825
PC Connection
CNXN
$2.11B
| $2.11M | ﹤0.01% |
34,092
+5,095
| +18% | +$325K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.